Vaxcyte (PCVX) CFO Andrew Guggenhime Surrenders Shares for Taxes

What Happened

• Andrew Guggenhime, President and Chief Financial Officer of Vaxcyte (PCVX), surrendered a total of 2,705 shares to cover tax withholding on vested restricted stock units (RSUs).
• Transactions: 1,273 shares at $60.74 on 2026-08-31 (value $77,322) and 1,432 shares at $61.58 on 2026-09-02 (value $88,183), totaling approximately $165,505.
• This was a tax-withholding disposal (routine), not an open-market sale — generally viewed as administrative and not a directional trade signal.

Key Details

• Transaction dates and prices:
  • 2026-08-31: 1,273 shares surrendered @ $60.74 = $77,322 (code F)
  • 2026-09-02: 1,432 shares surrendered @ $61.58 = $88,183 (code F)
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Footnotes:
  • F1: Shares were surrendered to the issuer to cover applicable tax withholding upon RSU vesting.
  • F2: Some shares are held by ALG 2025 GRAT HOLDINGS LLC, wholly owned by a grantor retained annuity trust for which the reporting person is annuitant and trustee.
• Filing: Form 4 filed 2026-09-02 for report period 2026-08-31. No late filing indicated in the provided data.

Context

• Code F indicates tax withholding on vested awards (share surrender). This is a routine administrative action when RSUs vest and does not necessarily reflect the insider's view on the company’s stock.
• For retail investors, purchases and open-market sales typically carry more interpretive weight than tax-withholding surrenders.